日本人体艺术下身

  • <tr id='TvvZfX'><strong id='TvvZfX'></strong><small id='TvvZfX'></small><button id='TvvZfX'></button><li id='TvvZfX'><noscript id='TvvZfX'><big id='TvvZfX'></big><dt id='TvvZfX'></dt></noscript></li></tr><ol id='TvvZfX'><option id='TvvZfX'><table id='TvvZfX'><blockquote id='TvvZfX'><tbody id='TvvZfX'></tbody></blockquote></table></option></ol><u id='TvvZfX'></u><kbd id='TvvZfX'><kbd id='TvvZfX'></kbd></kbd>

    <code id='TvvZfX'><strong id='TvvZfX'></strong></code>

    <fieldset id='TvvZfX'></fieldset>
          <span id='TvvZfX'></span>

              <ins id='TvvZfX'></ins>
              <acronym id='TvvZfX'><em id='TvvZfX'></em><td id='TvvZfX'><div id='TvvZfX'></div></td></acronym><address id='TvvZfX'><big id='TvvZfX'><big id='TvvZfX'></big><legend id='TvvZfX'></legend></big></address>

              <i id='TvvZfX'><div id='TvvZfX'><ins id='TvvZfX'></ins></div></i>
              <i id='TvvZfX'></i>
            1. <dl id='TvvZfX'></dl>
              1. <blockquote id='TvvZfX'><q id='TvvZfX'><noscript id='TvvZfX'></noscript><dt id='TvvZfX'></dt></q></blockquote><noframes id='TvvZfX'><i id='TvvZfX'></i>
                Artificial heart valves and transcather implantation systems
                The product which is interventive, minimally invasive, without surgical sutures and cardiopulmonary bypass is used to replace the diseased mitral valve. This new designed product can simplify the replacement surgery, significantly reducing the risks of treatment and increasing success rate. Moreover, this can shorten patients’ postoperative recovery time and cut down costs. Furthermore, reduced price of similar products enables more patients to have opportunities to endure risk and expense of surgery and treatment. As a revolutionary treatment, transcatheter artificial heart valve prosthesis is being well recognized by experts. In the future, clinical demands will grow explosively.
                人工心臟瓣膜及導管植∑入系統
                人工心臟瓣膜↑及導管植入系統具有介入、無手術縫線、無需體外循環和無須開胸手術等特點,用於置換心臟內病變的二尖瓣瓣将会永无止境膜。 這種新型產品將使心臟瓣膜置換手術過程簡化首领放心、治療風險大幅♂降低、成功率將顯著提高,同時也將縮←短病人術後恢復時間及大大降低費用→,拉低進口同類產品價格,使更多的病人能夠承受手術的風險和費那是用而得到治療。 介入▽人工心臟瓣膜作為一種革命性的々治療手段,正日益被專︼家所認同,在可預見的未來幾╳年內,臨床需求將會呈現♂爆發性的增長。